Castle Creek Biosciences
PrivateLast Round
Debt
Feb 25, 2025
Est. Valuation
$63.3M
Total Funding Raised
$272.9M
Company Overview
Castle Creek Biosciences is a biotechnology company that develops personalized cell and gene therapies aimed at addressing the root causes of rare skin and connective tissue diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Castle Creek Biosciences Comparables
Compare Castle Creek Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abeona Therapeutics Inc. | 81% | |
| Wings Therapeutics | 81% | |
| Krystal Biotech, Inc. | 79% | |
Castle Creek Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 25, 2025 | ||||
| VC Round | May 25, 2022 | ||||
| Convertible Debt | Jun 28, 2021 | ||||
| Series C | Mar 25, 2020 | ||||
| Debt | Mar 25, 2020 | ||||
M&A | Dec 16, 2019 |
Castle Creek Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ligand Pharmaceuticals | Debt |
| EB Research Partnership | Private Placement |
| Fidelity Management & Research Company | VC Round, Series B, Series C, Convertible Debt |
| Paragon Biosciences | Debt, VC Round, Series B, Series C |
| Horizon Technology Finance Corporation | Debt |
| Valor Equity Partners | Debt, VC Round, Series B, Series C |
| Third Security | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Lead candidate for dystrophic epidermolysis bullosa (DEB) enters pivotal trial.
- Apr 1, 2025
Lead candidate for DEB moves to pivotal Phase 3 trial, nearing BLA filing.
Castle Creek Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Castle Creek Biosciences's valuation, stock price, and market status.